In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...

There's nothing swampier than handing over billions of taxpayer dollars to a pharmaceutical company that had already gotten rich off the coronavirus pandemic.

Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused ...

By adjusting the fat levels in mRNA-based drugs, researchers have found a way to bypass the liver and go straight to the ...

A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...